Filgrastim is used in chemotherapy patients to reduce the risk of neutropenia by stimulating production of which type of blood cells?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

Filgrastim is used in chemotherapy patients to reduce the risk of neutropenia by stimulating production of which type of blood cells?

Explanation:
Filgrastim is a granulocyte colony-stimulating factor that prompts the bone marrow to increase production of neutrophils, a type of white blood cell. By boosting neutrophil counts, it reduces the risk and duration of chemotherapy-induced neutropenia, helping patients better fight infections. It does not inhibit neutrophil production or stimulate red blood cell production, and it doesn’t primarily affect platelets.

Filgrastim is a granulocyte colony-stimulating factor that prompts the bone marrow to increase production of neutrophils, a type of white blood cell. By boosting neutrophil counts, it reduces the risk and duration of chemotherapy-induced neutropenia, helping patients better fight infections. It does not inhibit neutrophil production or stimulate red blood cell production, and it doesn’t primarily affect platelets.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy